LIRAGLUTIDE (Diavic®)
Clinical Indication
Type 2 diabetes
Comments
Diavic® is the preferred liraglutide formulation across LLR.
Dec 2024 update: GLP-1 agonist Victoza to be discontinued | MIMS online
Date of classification
December 2024
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .